Publicité
Publicité
SXTP
60 Degrees Pharmaceuticals, Inc. Common Stock
0.54
USDSponsorisé
+0.03
+5.56%
09 janv., 15:27 UTC -5
Fermé
Après-marché
0.59
+0.05
+9.06%
SXTP Rapports sur les bénéfices
Ratio de surprise positive
SXTP a dépassé 2 des 9 dernières estimations.
22%
Prochain rapport
Date du prochain rapport
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Variation implicite de Q3 25 (Revenue/ EPS)
--
/--
Variation implicite de Q-- -1 (Revenue/ EPS)
--
/--
60 Degrees Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 13 nov. 2025, SXTP reported earnings of -0.66 USD per share (EPS) for Q3 25, beating the estimate of -1.23 USD, resulting in a 46.52% surprise. Revenue reached 528.56 mille, compared to an expected 408.00 mille, with a 29.55% difference. The market reacted with a -4.88% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analystes forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were 60 Degrees Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, 60 Degrees Pharmaceuticals, Inc. Common Stock reported EPS of -$0.66, beating estimates by 46.52%, and revenue of $528.56K, 29.55% above expectations.
How did the market react to 60 Degrees Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.88%, changed from $1.23 before the earnings release to $1.17 the day after.
When is 60 Degrees Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for 60 Degrees Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on --
analystes, 60 Degrees Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité